AstraZeneca obtains European approval for Duaklir Genuair to treat COPD

British-Swedish drugmaker AstraZeneca has received marketing approval from the European Commission (EC) for Duaklir Genuair (aclidinium bromide/formoterol fumarate 340/12mcg).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news